Lueken U, Seidl U, Schwarz M, Völker L, Naumann D, Mattes K, Schröder J, Schweiger E
Zentrum für Neuropsychologische Forschung, Universität Trier, Germany.
Fortschr Neurol Psychiatr. 2006 Dec;74(12):714-22. doi: 10.1055/s-2006-932164.
Apathy is a common feature of a variety of different psychiatric, neurological, and medical disorders. It can be defined as lack of motivation affecting cognitive, emotional, and overt behavioural aspects. Despite being associated with other clinical disorders, apathy can also occur as an independent syndrome (e. g., after brain injuries), now depicting a primary loss of motivation. However, apathy is predominantly assessed within the scope of superordinate psychiatric disorders. As a syndrome-independent scale, the Apathy Evaluation Scale (AES) claims to assess levels of apathy in different disorders. The aim of the present study is to provide German speaking researchers with an authorized German translation of the AES (AES (D)). The scale was evaluated in a sample of 217 subjects, consisting of patients suffering from dementia (n=120), remission-phase schizophrenia (n=20), Parkinson's disease (n=12), stroke (n=28), as well as elderly healthy controls (n=37). Preliminary results concerning the factorial structure, item characteristics, reliability, and construct validity demonstrate favourable statistical properties and suggest that the AESD is comparable to its original. The scale seems well-suited to detect apathy in different clinical groups. Differences between informant sources (clinician interview, self-, and informant ratings) seem to be related to the severity of symptoms or expert practice.
冷漠是多种不同精神、神经和医学疾病的常见特征。它可被定义为影响认知、情感和明显行为方面的动机缺乏。尽管与其他临床疾病相关,但冷漠也可作为一种独立综合征出现(例如,脑损伤后),目前表现为动机的原发性丧失。然而,冷漠主要是在上级精神疾病范围内进行评估。作为一种独立于综合征的量表,冷漠评估量表(AES)声称可评估不同疾病中的冷漠程度。本研究的目的是为德语研究人员提供AES的权威德语翻译版(AES(D))。该量表在217名受试者的样本中进行了评估,这些受试者包括痴呆患者(n = 120)、缓解期精神分裂症患者(n = 20)、帕金森病患者(n = 12)、中风患者(n = 28)以及老年健康对照者(n = 37)。关于因子结构、项目特征、信度和结构效度的初步结果显示出良好的统计学特性,表明AES(D)与其原版相当。该量表似乎非常适合检测不同临床群体中的冷漠情况。信息来源(临床医生访谈、自评和他人评定)之间的差异似乎与症状严重程度或专家实践有关。